Direct Answer
Neurology billing combines high-complexity E&M services with a rich set of diagnostic procedures — EEG, EMG/nerve conduction studies, evoked potentials — and therapeutic procedures including botulinum toxin injections, lumbar puncture, and neurostimulation device management. The most billing-intensive neurology procedures are EMG/NCS (which have strict NCCI bundling rules limiting the number of studies per limb) and botulinum toxin (where accurate CPT injection code selection PLUS drug-specific J-code billing with NDC documentation are both required). Neurology's diagnostic testing is predominantly office-based, creating significant global vs. TC/PC decisions similar to other procedure-intensive specialties.
Table of Contents
EEG Codes 95812-95830
Electroencephalography (EEG) CPT codes are organized by study duration and level of monitoring: Routine EEG: 95812 — EEG; 20-40 minutes of recording; 95813 — greater than 1 hour of recording; 95816 — awake and drowsy; up to 1 hour; 95819 — awake and asleep; up to 1 hour; 95822 — sleep only; Extended EEG monitoring: 95950 — ambulatory EEG 24-hour recording; 95951 — electroencephalographic (EEG) monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic and video recording and interpretation; 95956 — EEG monitoring, 24-hour recording; Video EEG (VEEG): 95951 — combined EEG + video for seizure localization; typically performed in an epilepsy monitoring unit (EMU); inpatient VEEG: billed daily during hospitalization; Magnetoencephalography (MEG): 95965 — magnetoencephalography recording and analysis; 95966 — each additional hour; Neonatal and pediatric EEG: 95822 — sleep only (often used for neonatal EEG); 95824 — cerebral death evaluation; TC/PC for EEG: when a neurologist interprets an EEG performed by a technician in a hospital: bill with Modifier 26 for professional interpretation only; the hospital bills the technical component; office-based EEG lab: bill global code; Documentation for EEG: the EEG report must include: clinical indication for the study; recording duration; montages used; background rhythm characterization; any abnormal findings (epileptiform discharges, slowing, focal abnormalities); clinical interpretation relating EEG findings to the patient's clinical condition; EEG reports should be dictated and signed, not templated without individualization.
EMG and Nerve Conduction Studies
EMG/NCS coding is among the most technically specific and audit-intensive in all of neurology: Nerve conduction studies (NCS): 95907 — nerve conduction studies, 1-2 studies; 95908 — 3-4 studies; 95909 — 5-6 studies; 95910 — 7-8 studies; 95911 — 9-10 studies; 95912 — 11-12 studies; 95913 — 13 or more studies; NCS codes count motor + sensory + mixed nerve studies as individual studies; F-wave studies and H-reflex studies count as individual studies; the total number of conduction studies determines the NCS code; EMG (needle electrode examination): 95860 — needle electromyography, 1 extremity with or without related paraspinal areas; 95861 — 2 extremities; 95863 — 3 extremities; 95864 — 4 extremities; 95865 — larynx; 95866 — hemidiaphragm; 95867 — cranial nerve supplied muscle(s); 95868 — cranial nerve supplied muscles, bilateral; 95869 — limited study of specific muscles other than thoracic paraspinal, cranial nerve supplied muscles, or sphincters; 95870 — limited study of specific muscles; 95885 — needle EMG, each extremity, with neuromuscular junction testing; 95886 — complete, 5 or more muscles; NCCI bundling for EMG/NCS: NCS and EMG codes can be reported together on the same day; however, specific bundling rules prevent billing certain combinations; the number of NCS studies is counted and reported as a single tiered code — NOT as multiple 95907 codes; example: 8 nerve conduction studies = 95910 (NOT 95907 × 4); Ordering and performing neurologist: if the ordering neurologist also performs and interprets the EMG/NCS, they bill all codes; if a different neurologist performs and interprets, the performing neurologist bills; the performing physician must be present during the examination; Remote interpretation only (without performing the test): bill with Modifier 26 for interpretation and report only.
Botulinum Toxin Injection Coding
Botulinum toxin injections require correct billing of both the injection procedure code and the drug J-code: Botulinum toxin procedure codes: 64612 — chemodenervation of muscle(s), muscle(s) innervated by facial nerve, unilateral (e.g., for blepharospasm, hemifacial spasm); 64615 — chemodenervation of muscle(s) innervated by facial, trigeminal, cervical spinal and accessory nerves, bilateral (e.g., for chronic migraine); 64616 — chemodenervation of muscle(s), neck muscle(s), excluding muscles of the larynx; 64617 — chemodenervation of muscle(s), larynx, unilateral; 64642 — chemodenervation of one extremity, 1-4 muscle(s); 64643 — each additional extremity, 1-4 muscle(s); 64644 — chemodenervation of one extremity, 5 or more muscle(s); 64645 — each additional extremity, 5 or more muscle(s); 64646 — trunk muscle(s), 1-5 muscle(s); 64647 — trunk muscle(s), 6 or more muscle(s); Botulinum toxin drug J-codes: J0585 — injection, onabotulinumtoxinA (Botox), 1 unit; J0586 — abobotulinumtoxinA (Dysport), 5 units; J0587 — rimabotulinumtoxinB (Myobloc), 100 units; J0588 — incobotulinumtoxinA (Xeomin), 1 unit; each J-code unit is specific to that drug's unit definition — units are NOT interchangeable between brands; the number of J-code units billed must match the actual units injected; NDC requirement: Medicare requires the 11-digit NDC of the specific vial dispensed to be reported on the claim with the J-code; document: units injected by muscle group, total units, NDC of the vial used; Modifier JW for drug waste: units from a single-use vial that are discarded (not administered to any patient) are billed with Modifier JW; wasted Botox is a significant billing issue — document waste in the record and bill with JW; Prior authorization for botulinum toxin: most commercial payers and many Medicare Advantage plans require PA for botulinum toxin; indication-specific PA documentation (cervical dystonia, spasticity, chronic migraine, blepharospasm) is required; failed prior treatment documentation may be required for migraine indication.
Lumbar Puncture and Other Procedures
Neurology practices perform a range of in-office and hospital-based procedures beyond EEG and EMG: Lumbar puncture: 62270 — spinal puncture, lumbar, diagnostic; 62272 — with drainage of spinal fluid; fluoroscopic guidance: 77003 (fluoroscopic guidance for needle placement) is separately billable when used; ultrasound guidance: 76942 (ultrasound guidance for needle placement) is separately billable; documentation must specify whether imaging guidance was used; Evoked potential studies: 95925 — short-latency somatosensory evoked potential study, stimulation of any/all peripheral nerves or skin sites, recording from the central nervous system; upper limbs; 95926 — lower limbs; 95928 — central motor evoked potential study, upper limbs; 95929 — lower limbs; 95930 — visual evoked potential testing, full field, with interpretation and report; 95938 — upper and lower limbs; visual evoked potentials (VEP): 95930 — used for optic neuritis, MS diagnosis; brainstem auditory evoked response (BAER/ABR): 92585 — auditory evoked potentials for evoked response audiometry and/or testing of the central nervous system; these tests have TC/PC billing rules when performed in hospital; Neurostimulation device management: spinal cord stimulators: 95970 — electronic analysis of implanted neurostimulator; 95971 — simple or complex brain, spinal cord, or peripheral nerve neurostimulator, without reprogramming; 95972/95973 — with simple/complex programming; Vagus nerve stimulator (VNS): 95970 for interrogation without reprogramming; deep brain stimulator (DBS): 95978 — analysis with reprogramming (complex); 95979 — each additional 30 minutes; Transcranial magnetic stimulation (TMS): 90867 — first treatment including mapping; 90868 — subsequent delivery and management; 90869 — subsequent motor threshold re-determination; TMS for depression requires prior authorization; most payers require documentation of failed antidepressant trials.
Neurology Denials and RCM
Neurology practices face specific denial patterns tied to their diagnostic and therapeutic procedure mix: Common neurology denial patterns: EMG/NCS medical necessity: payers require documentation of the specific clinical indication (radiculopathy, peripheral neuropathy, carpal tunnel) and how the EMG/NCS result will affect management; "rule out neuropathy" without clinical findings is insufficient; NCS tier code errors: billing multiple units of 95907 instead of the appropriate tiered code (95908-95913) for the total number of studies performed; NCCI edits catch this, but some errors reach payers; Botulinum toxin prior authorization: PA obtained for spasticity indication but injected for chronic migraine (or vice versa); ensure PA indication matches the clinical documentation and billing; Botulinum toxin drug waste: not billing Modifier JW for wasted drug; payer may deny the JW units as unbillable waste if not properly documented; EEG medical necessity: EEG performed as screening without documented clinical indication (seizure activity, altered consciousness, encephalopathy); TMS frequency denials: TMS requires documentation of adequate antidepressant trials before commercial coverage; frequency of treatment sessions (typically 36 sessions per acute course) must match the payer's coverage policy; Neurology RCM best practices: drug J-code accuracy is critical — Botox vs. Dysport vs. Xeomin are not interchangeable in billing; each visit with botulinum toxin should have complete documentation of muscle groups injected, units by muscle, total units, lot number, and NDC; EMG lab quality: perform and bill the appropriate number of studies for the clinical question — unnecessary studies that are billed are an audit target; necessary studies that are not performed result in incomplete diagnosis; maintain procedure documentation standards that specify: indication, technique, findings, and interpretation for every study.
FAQ
What are the documentation requirements for botulinum toxin injection in spasticity vs. chronic migraine?
Botulinum toxin has FDA-approved indications that correspond to specific CPT injection codes and payer coverage criteria. The documentation requirements differ by indication: For cervical dystonia (onabotulinumtoxinA — Botox, or abobotulinumtoxinA — Dysport): procedure code: 64616 (chemodenervation, neck muscles); documentation required: diagnosis of cervical dystonia (ICD-10 G24.3); examination findings documenting the dystonic posture (torticollis, laterocollis, retrocollis); functional impairment; prior treatment and response history; units injected by muscle group; total units; NDC and lot number; For spasticity (upper or lower extremity): procedure codes: 64642-64645 (by extremity and number of muscles); documentation: diagnosis (G80.x — cerebral palsy, G81 — hemiplegia, G35 — MS, etc.); Modified Ashworth Scale (MAS) or other spasticity severity measure; functional goal of treatment; muscles injected with individual units; prior response; For chronic migraine (onabotulinumtoxinA — Botox only — FDA approved for chronic migraine): procedure code: 64615 (bilateral, facial/cervical/accessory nerve muscles); requires PREEMPT injection protocol (31 fixed-site injections, 155 units minimum) or follow-on sets; documentation: chronic migraine diagnosis (15+ headache days/month, 8+ migraine days/month for 3+ months — G43.709); failed prior prophylactic medications (typically 2-3 classes: beta-blocker, TCA, anticonvulsant, CGRP antagonist); units by injection site (standard PREEMPT chart documentation); For blepharospasm: procedure code: 64612; documentation: benign essential blepharospasm diagnosis; functional visual impairment; prior treatment; prior authorization: PA is required for virtually all botulinum toxin indications from commercial payers; submit the indication-specific documentation and expected course of treatment (typically every 3 months for all indications).
How many EMG/NCS studies can a neurologist perform and bill in a single session?
There is no absolute CPT or Medicare limit on the number of EMG/NCS studies per session, but medical necessity and NCCI bundling rules constrain what can appropriately be billed: What determines appropriate NCS study count: the clinical question drives the appropriate studies; carpal tunnel evaluation: typically 3-4 studies (median motor, median sensory, ulnar motor or sensory for comparison, F-wave); polyneuropathy evaluation: typically 5-8 studies (bilateral lower extremity motor and sensory, ± F-waves); radiculopathy evaluation: typically 4-6 motor and sensory studies relevant to the affected root level; EMG + NCS: EMG extremity codes and NCS tiered codes are reported separately; a complete unilateral upper extremity evaluation with EMG of one extremity (95860) + 6 NCS studies (95909) is appropriate for carpal tunnel with radiculopathy questions; NCCI bundling that applies: 95907 (1-2 NCS) is the base code; additional studies are reported as the higher tiered code covering all studies — NOT as multiple 95907 units; 95860 (1 extremity EMG) and 95913 (13+ NCS) can be billed together if the clinical question warrants both; Medical necessity documentation for extensive studies: when billing 13+ studies (95913), the clinical documentation must clearly support the medical necessity for the scope of the evaluation; a note documenting "polyneuropathy evaluation, ruling out length-dependent axonal neuropathy vs. demyelinating neuropathy vs. vasculitic process" supports a comprehensive bilateral study; a note documenting "rule out carpal tunnel" does not support 13+ studies; Audit risk: EMG/NCS is a Medicare audit target; the clinical question must match the scope of study; documentation in the EDX report must show each individual study performed and its result, supporting the tier code billed; inadequate documentation for high-tier NCS codes is a top audit finding in neurology.
Neurology RCM Expertise From EEG to Botulinum Toxin to EMG
Valiant Lifecare's neurology billing specialists understand EEG TC/PC billing, EMG/NCS tier code selection and NCCI bundling, botulinum toxin injection codes with J-code and NDC documentation, lumbar puncture and evoked potential billing, and the prior authorization and denial management strategies that protect neurology practice revenue.
Optimize Your Neurology Revenue Cycle